(Q34138396)

31 July 2017

title

Perspectives of Kennedy's disease (English)

1 reference

31 July 2017

J. Finsterer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846673

14 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20846673

14 July 2024

publication date

16 September 2010

1 reference

full work available at URL

31 July 2017

https://api.elsevier.com/content/article/PII:S0022510X10003928?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

https://api.elsevier.com/content/article/PII:S0022510X10003928?httpAccept=text/plain

14 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Journal of the Neurological Sciences

14 July 2024

published in

1 reference

31 July 2017

volume

298

1 reference

31 July 2017

issue

1-2

1 reference

31 July 2017

page(s)

1-10

1 reference

Men with Kennedy disease have a reduced risk of androgenetic alopecia

31 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Spinal and bulbar muscular atrophy: a motoneuron or muscle disease?

14 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy

14 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait

14 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Hereditary motor neuron disease: the proximal, adult, sex-linked form (or Kennedy disease). Clinical and neuroendocrinologic observations

14 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Localization of the gene for X-linked spinal muscular atrophy

14 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

14 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy

14 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice

14 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Trinucleotide repeat disease. The androgen receptor in spinal and bulbar muscular atrophy

14 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy

14 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Distal spinal and bulbar muscular atrophy caused by dynactin mutation.

14 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Epidemiological survey of X-linked bulbar and spinal muscular atrophy, or Kennedy disease, in the province of Reggio Emilia, Italy

14 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases

14 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Phenotypic differences in a large family with Kennedy's disease from the Middle Black Sea region of Turkey

14 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients

14 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

X-linked bulbospinal neuronopathy: Kennedy disease

14 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Phenotypic variability in Kennedy's disease: implication of the early diagnostic features

14 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

A phenotypic-genetic study of a group of Polish patients with spinal and bulbar muscular atrophy.

14 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Clinical features of spinal and bulbar muscular atrophy

14 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA.

14 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Familial case of late recessive X-linked Kennedy's spinal and bulbar amyotrophy

14 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Multimodal evoked potentials of Kennedy's disease.

14 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

X-linked recessive bulbospinal neuronopathy: a report of ten cases

14 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Abnormal eye movements in Kennedy disease

14 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Quinine-responsive muscle cramps in X-linked bulbospinal muscular atrophy Kennedy

14 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Pure bulbar motor neuron involvement linked to an abnormal CAG repeat expansion in the androgen receptor gene

14 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Dysphagia in X-linked bulbospinal muscular atrophy (Kennedy disease)

14 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy

14 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Upper motor neuron involvement in X-linked recessive bulbospinal muscular atrophy.

14 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Are cognitive and behavioural deficits a part of the clinical picture in Kennedy's disease? A case study.

14 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Elevated creatine kinase and transaminases in asymptomatic SBMA

14 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Determinants of double discharges in amyotrophic lateral sclerosis and Kennedy disease

14 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Fatigue and abnormal neuromuscular transmission in Kennedy's disease

14 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Muscle MRI findings of X-linked spinal and bulbar muscular atrophy

14 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females.

14 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Very late onset X-linked recessive bulbospinal neuronopathy: mild clinical features and a mild increase in the size of tandem CAG repeat in androgen receptor gene

14 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model.

14 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker

14 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy

14 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women

14 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Highly skewed inactivation of the wild-type X-chromosome in asymptomatic female carriers of spinal and bulbar muscular atrophy (Kennedy's disease).

14 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

The role of the polyglutamine tract in androgen receptor.

14 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Autophagy and access: understanding the role of androgen receptor subcellular localization in SBMA.

14 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Consequences of poly-glutamine repeat length for the conformation and folding of the androgen receptor amino-terminal domain

14 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism

14 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

The androgen receptor gene: a major modifier of speed of neuronal transmission and intelligence?

14 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

DNA diagnosis of X-linked recessive bulbospinal muscular atrophy by androgen receptor gene mutations

14 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Kennedy's disease: a clinicopathologic correlation with mutations in the androgen receptor gene

14 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Disease-associated mutations in the p150(Glued) subunit destabilize the CAP-gly domain

14 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Molecular Genetics and Biomarkers of Polyglutamine Diseases

14 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

CAG repeat disorder models and human neuropathology: similarities and differences

14 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

The advances in research on phosphorylation of polyglutamine disease

14 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity

14 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Kennedy's disease. Phosphorylation of the polyglutamine-expanded form of androgen receptor regulates its cleavage by caspase-3 and enhances cell death

14 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy.

14 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Polyglutamine-expanded androgen receptor truncation fragments activate a Bax-dependent apoptotic cascade mediated by DP5/Hrk

14 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity.

14 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Mitochondrial abnormalities in spinal and bulbar muscular atrophy

14 July 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Depletion of mitochondrial DNA in leukocytes of patients with poly-Q diseases

14 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration.

14 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

X-linked recessive bulbospinal neuronopathy. A clinicopathological study

14 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients.

14 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Primary sensory neurons in X-linked recessive bulbospinal neuropathy: histopathology and androgen receptor gene expression

14 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Age-dependent differences in androgen binding affinity in a family with spinal and bulbar muscular atrophy

14 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Testosterone therapy and the pathogenesis of Kennedy's disease (X-linked bulbospinal muscular atrophy)

14 July 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Administration of testosterone results in reversible deterioration in Kennedy's disease

14 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives

14 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Five year follow up of a patient with spinal and bulbar muscular atrophy treated with leuprorelin

14 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy

14 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease

14 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease

14 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein

14 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse

14 July 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration

14 July 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor

14 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy.

14 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Natural history of spinal-bulbar muscular atrophy.

14 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy

14 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

Androgen receptor and Kennedy disease/spinal bulbar muscular atrophy

14 July 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.025

14 July 2024

Identifiers

1 reference

31 July 2017

1 reference